JNJ · News · 20260916N

Acquisition / Partnership / Divestiture

JOHNSON & JOHNSON · 2026-09-16 · Importance 34 · Surprise 42

Johnson & Johnson is selling the assets of Laminar, a company it acquired in November 2023 for its left atrial appendage closure device. The divestiture follows suspension of Laminar’s pivotal trial because of safety concerns. Jaguar LAA, a newly formed company backed by Santé Ventures, is acquiring the assets and plans to continue developing the technology, allowing J&J to focus resources on higher-growth areas of its MedTech portfolio.